Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,328 | 512 | 89.8% |
| Travel and Lodging | $971.66 | 2 | 9.4% |
| Education | $82.99 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $1,352 | 7 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $1,228 | 83 | $0 (2024) |
| Abbott Laboratories | $1,097 | 52 | $0 (2024) |
| PFIZER INC. | $975.55 | 76 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $816.81 | 43 | $0 (2024) |
| Amgen Inc. | $756.43 | 41 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $741.29 | 37 | $0 (2024) |
| Merck Sharp & Dohme LLC | $466.16 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $385.02 | 22 | $0 (2024) |
| Amarin Pharma Inc. | $364.03 | 21 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,443 | 63 | Abbott Laboratories ($286.24) |
| 2023 | $1,461 | 69 | E.R. Squibb & Sons, L.L.C. ($197.67) |
| 2022 | $920.68 | 49 | Janssen Pharmaceuticals, Inc ($249.92) |
| 2021 | $1,146 | 72 | Amarin Pharma Inc. ($193.09) |
| 2020 | $1,180 | 68 | Amgen Inc. ($269.90) |
| 2019 | $977.04 | 67 | Amgen Inc. ($167.12) |
| 2018 | $2,264 | 65 | Medtronic Vascular, Inc. ($1,352) |
| 2017 | $991.09 | 62 | Abbott Laboratories ($270.63) |
All Payment Transactions
515 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | Abbott Laboratories | MERLIN@HOME (Device) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $32.79 | General |
| Category: Cardiovascular | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $3.28 | General |
| Category: Cardiovascular | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.53 | General |
| Category: Cardiovascular | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $3.02 | General |
| Category: Cardiovascular | ||||||
| 10/16/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/07/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/17/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $39.65 | General |
| Category: Coronary | ||||||
| 09/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Obesity | ||||||
| 08/26/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $31.57 | General |
| Category: Cardiology | ||||||
| 08/21/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/20/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.74 | General |
| Category: Cardiovascular | ||||||
| 08/14/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.95 | General |
| 07/23/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $157.03 | General |
| Category: Cardiac Rhythm Management | ||||||
| 07/23/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: Cardiac Rhythm Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,371 | 2,062 | $467,624 | $120,833 |
| 2022 | 12 | 1,029 | 1,650 | $303,568 | $87,127 |
| 2021 | 13 | 859 | 1,183 | $254,379 | $76,514 |
| 2020 | 18 | 1,214 | 1,675 | $401,014 | $95,352 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 200 | 392 | $92,904 | $36,120 | 38.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 98 | 135 | $41,175 | $18,397 | 44.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 109 | 113 | $120,200 | $18,044 | 15.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 236 | 531 | $37,170 | $5,907 | 15.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 30 | 30 | $30,120 | $5,889 | 19.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 49 | 64 | $14,656 | $5,869 | 40.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 30 | 31 | $24,366 | $4,567 | 18.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 37 | 37 | $10,878 | $3,953 | 36.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 73 | 73 | $18,031 | $3,866 | 21.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 374 | 514 | $17,476 | $3,423 | 19.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 53 | $8,374 | $3,338 | 39.9% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 23 | 23 | $15,847 | $2,820 | 17.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $6,035 | $2,034 | 33.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,220 | $2,030 | 38.9% |
| 93268 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | Office | 2023 | 13 | 13 | $10,231 | $1,991 | 19.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 11 | 11 | $8,558 | $1,531 | 17.9% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 12 | 13 | $6,383 | $1,054 | 16.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 216 | 453 | $107,361 | $42,389 | 39.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 81 | 82 | $80,938 | $13,670 | 16.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 41 | 56 | $17,080 | $8,320 | 48.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 242 | 533 | $37,310 | $5,907 | 15.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $13,490 | $3,983 | 29.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 43 | 59 | $9,322 | $3,517 | 37.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 13 | 13 | $9,498 | $2,172 | 22.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 260 | 316 | $10,400 | $2,121 | 20.4% |
About Dr. Maria Santos, M.D
Dr. Maria Santos, M.D is a Cardiovascular Disease healthcare provider based in Bloomfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2010. The National Provider Identifier (NPI) number assigned to this provider is 1821316274.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maria Santos, M.D has received a total of $10,382 in payments from pharmaceutical and medical device companies, with $1,443 received in 2024. These payments were reported across 515 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($9,328).
As a Medicare-enrolled provider, Santos has provided services to 4,473 Medicare beneficiaries, totaling 6,570 services with total Medicare billing of $379,826. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Bloomfield, CT
- Active Since 05/10/2010
- Last Updated 10/20/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1821316274
Products in Payments
- XARELTO (Drug) $1,207
- ELIQUIS (Drug) $692.04
- ENTRESTO (Drug) $565.54
- VERQUVO (Drug) $466.16
- Repatha (Biological) $454.03
- CAMZYOS (Drug) $421.96
- Vascepa (Drug) $364.03
- CHANTIX (Drug) $337.49
- Corlanor (Drug) $302.40
- AVEIR (Device) $232.27
- FARXIGA (Drug) $228.22
- VYNDAQEL (Drug) $215.05
- Arcalyst (Drug) $210.34
- LEQVIO (Drug) $175.75
- CRT-Ds (Device) $162.33
- JARDIANCE (Drug) $160.26
- CARDIOMEMS (Device) $146.53
- LifeVest (Device) $140.21
- NEXLETOL (Drug) $140.21
- Confirm Rx (Device) $136.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Bloomfield
Brett Nowlan, Md, MD
Cardiovascular Disease — Payments: $951,843
Ronald Bloom, M.d, M.D
Cardiovascular Disease — Payments: $30,875
Dr. Alan Lapa, M.d, M.D
Cardiovascular Disease — Payments: $28,329
Tracy Patel, M.d, M.D
Cardiovascular Disease — Payments: $13,103
Vincent Romano, M.d, M.D
Cardiovascular Disease — Payments: $11,581
Dr. Catalino Delacruz, M.d, M.D
Cardiovascular Disease — Payments: $10,399